Publications by authors named "Rana Mekdashi"

Article Synopsis
  • - The effectiveness of the BBIBP-CorV COVID-19 vaccine is low in populations that received two doses, prompting interest in alternative vaccination strategies.
  • - A study at Makassed General Hospital tested the safety and effectiveness of a BNT162b2 booster dose for individuals who had completed the BBIBP-CorV regimen, finding higher antibody levels and good tolerability with heterologous vaccination.
  • - Mixing the BBIBP-CorV and BNT162b2 vaccines shows promise for enhancing immunity in areas lacking access to mRNA vaccines, potentially offering better protection against new variants.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Rana Mekdashi"

  • - Rana Mekdashi's research primarily focuses on the immunogenicity and reactogenicity of COVID-19 vaccines, particularly the BNT162b2 booster in individuals previously vaccinated with BBIBP-CorV.
  • - The pilot study conducted in Lebanon revealed that the BBIBP-CorV vaccine had low effectiveness, leading to an investigation into heterologous vaccination strategies that could enhance immune responses.
  • - Findings indicated that a combination of BBIBP-CorV followed by BNT162b2 vaccination produced better immunogenicity compared to receiving two doses of the same BBIBP-CorV vaccine, suggesting promising avenues for vaccine regimen optimization.